Papillary serous carcinoma of peritoneum: presentation of 2 cases

Clin Transl Oncol. 2006 Oct;8(10):758-60. doi: 10.1007/s12094-006-0124-7.

Abstract

Papillar serous carcinoma of peritoneum (PSPC) is an unfrequent neoplasm, histologically similar to papillar serous carcinoma of ovarium. It presents as peritoneal carcinomatosis without evident tumoral focus. Management of PSPC is similar to ovaric neoplasms, although prognosis should be worse. Long-term survival has been described with cytoreductive surgery and adjuvant chemotherapy with platinum. We present hereby 2 cases of PSPC.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Phytogenic
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carboplatin / administration & dosage
  • Carboplatin / therapeutic use
  • Carcinoma, Papillary* / diagnostic imaging
  • Carcinoma, Papillary* / drug therapy
  • Carcinoma, Papillary* / mortality
  • Carcinoma, Papillary* / surgery
  • Chemotherapy, Adjuvant
  • Cisplatin / administration & dosage
  • Cisplatin / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Paclitaxel / administration & dosage
  • Paclitaxel / therapeutic use
  • Peritoneal Neoplasms* / diagnostic imaging
  • Peritoneal Neoplasms* / drug therapy
  • Peritoneal Neoplasms* / mortality
  • Peritoneal Neoplasms* / surgery
  • Postoperative Care
  • Radiography, Abdominal
  • Time Factors
  • Tomography, X-Ray Computed
  • Topotecan / administration & dosage
  • Topotecan / therapeutic use
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Topotecan
  • Carboplatin
  • Paclitaxel
  • Cisplatin